Moleculin Biotech
MBRX
MBRX
20 hedge funds and large institutions have $1.78M invested in Moleculin Biotech in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$294K | |
| 2 | +$179K | |
| 3 | +$94.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$89.3K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$40.1K |
Top Sellers
| 1 | -$170K | |
| 2 | -$22K | |
| 3 | -$21K | |
| 4 |
VF
Virtu Financial
New York
|
-$13K |
| 5 |
BlackRock
New York
|
-$3.71K |